Bio/Pharma Business

Data analytic strategies can help companies capitalize on personalized medicine.

Partnership is awarded for licensing of low-cost vaccine for the treatment of bacterial meningitis.

GSK is found guilty of offering bribes to doctors and is fined $489 million.

A review of how mergers and acquisitions have shaped the pharmaceutical industry landscape.

After rejecting several bids, Shire has agreed to a merger with AbbVie valued at almost $55 billion.

Mylan set to acquire Abbott's non-US developed markets specialty and branded generics business in an all-stock transaction.

Sandoz will supply antibiotic to developing countries as part of the United Nations' Every Newborn Action Plan.

GSK and Save the Children announce criteria for awards that recognize innovation in healthcare for the world&s poorest children.

PharmSource special report shows demand for cytotoxic injectable drugs could tap existing CMO capacity.

Pharma companies are looking to external sources for innovations that meet future needs.

Novartis' 13th Annual Malaria Expert Panel focused on access to quality anti-malarials across Africa.

PhRMA announced 430 new medicines in development to treat chronic diseases affecting older Americans.

Protecting intellectual property rights is vital to biopharmaceutical innovation.

ASCO meeting attendees give artistic interpretations of cancer journeys in the form of public Hope Murals.

Pfizer and the Avon Foundation for Women Breast Cancer Grants Program will award up to $1 million in grants to advocacy, academic, and other not-for-profit organizations.

GSK reports 5-year vaccine price freeze for countries graduating from GAVI Alliance.

Kymab receives $40 million investment for clinical development of antibody therapeutics.

AstraZeneca rejects Pfizer's final offer of $118 billion for a proposed merger of the two companies.

Tigermed acquires Frontage Laboratories for $50.25 million.

The Fogarty International Center, a component of the US NIH, calls for a focus on noncommunicable diseases and implementing science in low-resource settings.

Janssen Pharmaceutical collaborates with Stop TB Partnership's Global Drug Facility to increase access to anti-TB compound.

Bristol-Myers Squibb is named No. 1 on 2014 Best Corporate Citizens List for the third time in six years.

Eli Lilly has developed the Lilly Medical Student Intern Program for future physicians.

Novartis' eBook features images of meningococcal disease survivors from around the world.

UPM will commercially manufacture two ANDA products for Amerigen Pharmaceuticals.

Portfolio swaps between Novartis and GSK involve oncology, vaccines, and consumer products.

Sun Pharma acquisition of Ranbaxy Laboratories will create the fifth-largest specialty generics company in the world.

The I'm In campaign is designed to increase participation by diverse patient populations for clinical trials.

Crystal Pharmatech selects Freeslate for its CM Protege PharmD System.

Lilly Diabetes supports the American Diabetes Association for the seventh year in a row.